• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625358003
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Intracranial Hemorrhage (1891); Movement Disorder (4412); Speech Disorder (4415)
Event Date 10/05/2021
Event Type  Injury  
Manufacturer Narrative
Occupation is patient/consumer (patient's husband).The meter and test strips were requested for investigation, however, the test strips are no longer available to return.The meter was returned for investigation.Relevant retention test strips (lot 51508710) were measured with the returned meter with a high level control sample: testing results (qc range: 2.6 - 3.2 inr): qc 1: 2.9 inr qc 2: 3.0 inr qc 3: 2.9 inr all inr values were within the specified target ranges, confirming the functionality of the complained coaguchek meter.No error messages occurred.The returned customer material and retention material comply with the specification.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.
 
Event Description
We received an allegation of questionable inr results which reportedly contributed to a light brain hemorrhage and hospitalization for 1 patient testing with coaguchek xs meter serial number#: (b)(4).The reporter stated the event occurred on either (b)(6) 2021 or (b)(6) 2021.The results from the coaguchek xs meter were reported to be within the patient's therapeutic range.The patient¿s therapeutic range was requested but was not provided.The reporter only provided a target value of 2.5 inr.On either (b)(6) 2021 or (b)(6) 2021 the patient reportedly felt "ill" and the patient was reportedly taken to the hospital by ambulance.At the hospital the patient¿s result was reportedly 4.4 inr or 4.5 inr.The reporter could not remember the exact result.The patient reportedly had a ct scan where a light brain hemorrhage was identified.The patient reportedly had an operation to remove the hemorrhage and stop the bleeding.The patient was reportedly in the hospital for 14 days.Following the patient¿s release from the hospital, she reportedly started bridging with marcumar as advised by the hospital.The patient is reportedly currently undergoing cognitive and physical therapy due to issues with amnesic aphasia and issues related to walking properly.The patient¿s husband stated that apart from that, the patient is reportedly feeling fine and her inr is currently within the expected range.The reporter did not provide any specific inr results leading up to the event.On review of the returned meter memory, the last result prior to the alleged date of event was 2.6 inr on (b)(6) 2021.Additional information was requested, but has not been received at this time.This information includes: whether there were any medication adjustments based on meter results leading up to the event further details related to therapy at the hospital (e.G.Medications, bridging, marcumar dosage changes).The cause of the light brain hemorrhage and bleeding this mdr is being submitted in an abundance of caution.
 
Manufacturer Narrative
Section a2, age was updated.Section a4, weight was updated.Section b7 was updated.Based on information obtained from the returned meter, the test strip lot number used at the time of the event could be determined.Sections d1, d4 catalog number, d4 lot number and d4 udi# were updated.Section d10 was updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12910326
MDR Text Key286838417
Report Number1823260-2021-03546
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/01/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number04625358003
Device Lot Number515087
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/03/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CONCOR; FALITHROM; MARCUMAR; UNSPECIFIED PAINKILLERS ¿ AS NEEDED
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age80 YR
Patient SexFemale
Patient Weight74 KG
-
-